Which company is the manufacturer of daprostat?
Daprodustat (Daprodustat) is an oral small molecule HIF-PH inhibitor developed and produced by GlaxoSmithKline (GSK), the world's leading pharmaceutical company. It is specially used to treat chronic kidney disease-related anemia (CKD-anemia). GSK is a multinational pharmaceutical company headquartered in the UK. It has a profound research foundation in the field of chronic disease treatment and has accumulated a large amount of clinical experience in kidney diseases and blood system diseases.
Daprostat is one of the company's important innovative drugs in the field of kidney disease management, marking its strategic transformation from traditional injectable erythropoietin drugs to oral innovative therapies. The drug was first approved for marketing in Japan, and has since been approved in many countries and regions such as the United States and the European Union for the treatment of anemia in dialysis and non-dialysis CKD patients.

In the European and American markets, daprostat is sold under the trade nameJesduvroq, while in the Japanese market it is sold under the brand name Duvroq. At present, daprostat has not been officially approved for marketing in mainland China. As one of the world's leading biopharmaceutical companies, GlaxoSmithKline has conducted multiple multi-center, large-sample, randomized controlled clinical trials on daplestat. Its research and development and production processes strictly follow GMP regulations and have a high degree of drug quality control capabilities.
In addition, in order to ensure the supply of dapocestat in the global market,GSK has deployed production chains and sales channels in multiple countries to ensure stable access to drugs. In the future, as more countries become more accepting of oral HIF-PH inhibitors, daprostat is expected to become an important player in the international renal anemia treatment field. Its R&D company, GlaxoSmithKline, will also continue to promote the global registration and indication expansion of the drug.
Reference materials:https://en.wikipedia.org/wiki/Daprodustat
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)